Publications found:
36,694
Sort by:
Myocarditis (Cardiovascular) - Drugs In Development, 2021
US$ 2,000.00
Myocarditis (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myocarditis (Cardiovascular) - Drugs In Developmen...
June 2021
57 pages
Pressure Ulcers (Dermatology) - Drugs In Development, 2021
US$ 2,000.00
Pressure Ulcers (Dermatology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pressure Ulcers (Dermatology) - Drugs In Developm...
June 2021
30 pages
Pruritus (Dermatology) - Drugs In Development, 2021
US$ 2,000.00
Pruritus (Dermatology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pruritus (Dermatology) - Drugs In Development, 2021, pro...
June 2021
221 pages
Restenosis (Cardiovascular) - Drugs In Development, 2021
US$ 2,000.00
Restenosis (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Restenosis (Cardiovascular) - Drugs In Development,...
June 2021
40 pages
Tyrosine Protein Kinase Mer - Drugs In Development, 2021
US$ 3,500.00
Tyrosine Protein Kinase Mer - Drugs In Development, 2021 SUMMARY According to the recently published report 'Tyrosine Protein Kinase Mer - Drugs In Development, 2021'; Tyrosine Protein Kinase Mer (Pro...
June 2021
94 pages
Vaccine Delivery Devices: Global Markets
US$ 5,500.00
Report This report provides a detailed description of vaccine delivery devices and the latest technologies in the market. The report includes market estimates for different types of vaccine delivery...
June 2021
141 pages
Investigation Report on China's Anlotinib Market 2021-2025
US$ 2,600.00
Anlotinib is an oral multi-targeting small-molecule tyrosine kinase inhibitor that can target multiple angiogenic factor receptors to inhibit tumor angiogenesis. It can be used for advanced non-small...
June 2021
50 pages
Investigation Report on China's Goserelin Market 2021-2025
US$ 2,600.00
Goserelin is a synthetic analogue of a naturally occurring gonadotropin-releasing hormone (GnRH). Goserelin is developed by AstraZeneca, is mainly used to treat advanced breast and prostate cancer. In...
June 2021
50 pages
Global Erythropoietin Drugs Market Size study, By Drug Class (Biologics, Biosimilars), By Product (Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa, Others), By Application (Cancer, Hematology, Neurology and Renal Diseases) and Regional Forecasts 2021-2027
US$ 3,000.00
Global Erythropoietin Drugs Market is valued approximately USD 11.05 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 11.30% over the forecast period 2021-2027. Eryth...
June 2021
200 pages
Global Vitamin D Therapy Market Size study, by Route of administration (Oral and Parenteral), Age Group (Children, Adult, Senior Adult), Purchase Pattern (OTC, Prescription), Application (Osteoporosis, Rickets, Autoimmune Disorder, Skin Diseases and Others) and Regional Forecasts 2021-2027
US$ 3,000.00
Global Vitamin D Therapy Market is valued approximately USD 2.11 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 11.3% over the forecast period 2021-2027. Vitamin D...
June 2021
200 pages
Pharmaceutical Caps and Closures Market Size study, by Product Type (Screw-on Caps, Dispensing Caps and Others) by Technology (Injection Moulding, Compression Moulding, Post-mould TE Band, Others) By Raw Material (PP, HDPE, LDPE and others), By End-use (Beverage, Pharmaceuticals and others) and Regional Forecasts 2021-2027.
US$ 3,000.00
Global Pharmaceutical Caps and Closures Market is valued at approximately USD 34.50 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 5.4% over the forecast period 202...
June 2021
200 pages
Investigation Report on China's Docetaxel Market 2021-2025
US$ 2,600.00
Docetaxel, sold under the brand name Taxotere, is a paclitaxel anti-tumor drug used for the treatment of locally advanced or metastatic non-small cell lung cancer. Docetaxel injection was first develo...
June 2021
50 pages
Investigation Report on China's Omalizumab Market 2021-2025
US$ 2,600.00
Omalizumab, developed by Novartis Europharm, is the only approved antibody designed to target and block immunoglobulin E (IgE). At the end of 2017, the FDA approved the registration of Novartis Europh...
June 2021
50 pages
Investigation Report on China's Pertuzumab Market 2021-2025
US$ 2,600.00
Pertuzumab is the first monoclonal antibody called 'HER dimerization inhibitor'. It mainly used to treat HER2-positive breast cancer. It was developed by Genentech, a subsidiary of Roche Pharma (Schwe...
June 2021
50 pages
Drug Discovery Informatics - Global Market Outlook (2020-2028)
US$ 4,150.00
... Drug Discovery Informatics market. However, Lack of information technology and critical attributes of data evaluation are limiting the market growth. The recent trends in Drug Discovery Informatics are considerable shift observed from traditional in-vitro drug development to computer aided drug designing, as costly failures of late drug development increases ...
June 2021
150 pages
